Susquehanna International Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
111,399
+17,729
| +19% | +$361K | ﹤0.01% | 2139 |
|
|
2025
Q1 | $1.7M | Buy |
93,670
+27,636
| +42% | +$502K | ﹤0.01% | 2519 |
|
|
2024
Q4 | $1.67M | Buy |
66,034
+1,458
| +2% | +$36.8K | ﹤0.01% | 2222 |
|
|
2024
Q3 | $2.19M | Buy |
64,576
+16,759
| +35% | +$570K | ﹤0.01% | 1773 |
|
|
2024
Q2 | $1.77M | Sell |
47,817
-23,401
| -33% | -$866K | ﹤0.01% | 1884 |
|
|
2024
Q1 | $2.99M | Buy |
71,218
+22,330
| +46% | +$937K | ﹤0.01% | 1416 |
|
|
2023
Q4 | $1.94M | Sell |
48,888
-8,572
| -15% | -$340K | ﹤0.01% | 1982 |
|
|
2023
Q3 | $1.58M | Buy |
57,460
+44,576
| +346% | +$1.23M | ﹤0.01% | 2055 |
|
|
2023
Q2 | $437K | Sell |
12,884
-48,522
| -79% | -$1.65M | ﹤0.01% | 3792 |
|
|
2023
Q1 | $2.21M | Buy |
61,406
+8,246
| +16% | +$297K | ﹤0.01% | 1846 |
|
|
2022
Q4 | $2.37M | Sell |
53,160
-88,391
| -62% | -$3.94M | ﹤0.01% | 1455 |
|
|
2022
Q3 | $3.98M | Buy |
141,551
+119,586
| +544% | +$3.36M | ﹤0.01% | 1008 |
|
|
2022
Q2 | $592K | Sell |
21,965
-80,737
| -79% | -$2.18M | ﹤0.01% | 3128 |
|
|
2022
Q1 | $3.5M | Buy |
102,702
+18,213
| +22% | +$620K | ﹤0.01% | 1455 |
|
|
2021
Q4 | $3.27M | Sell |
84,489
-69,471
| -45% | -$2.68M | ﹤0.01% | 1530 |
|
|
2021
Q3 | $8.31M | Buy |
153,960
+47,512
| +45% | +$2.57M | ﹤0.01% | 859 |
|
|
2021
Q2 | $3.56M | Sell |
106,448
-524,561
| -83% | -$17.5M | ﹤0.01% | 1535 |
|
|
2021
Q1 | $13M | Buy |
631,009
+319,272
| +102% | +$6.58M | ﹤0.01% | 639 |
|
|
2020
Q4 | $5.46M | Buy |
+311,737
| New | +$5.46M | ﹤0.01% | 946 |
|
|
2020
Q3 | – | Sell |
-13,863
| Closed | -$180K | – | 4478 |
|
|
2020
Q2 | $180K | Sell |
13,863
-19,298
| -58% | -$251K | ﹤0.01% | 3757 |
|
|
2020
Q1 | $55K | Sell |
33,161
-28,548
| -46% | -$47.3K | ﹤0.01% | 4189 |
|
|
2019
Q4 | $138K | Buy |
61,709
+21,256
| +53% | +$47.5K | ﹤0.01% | 3609 |
|
|
2019
Q3 | $86K | Buy |
+40,453
| New | +$86K | ﹤0.01% | 4113 |
|
|
2019
Q2 | – | Sell |
-23,882
| Closed | -$117K | – | 4555 |
|
|
2019
Q1 | $117K | Buy |
23,882
+15,802
| +196% | +$77.4K | ﹤0.01% | 2651 |
|
|
2018
Q4 | $24K | Buy |
+8,080
| New | +$24K | ﹤0.01% | 3429 |
|
|
2018
Q2 | – | Sell |
-9,376
| Closed | -$328K | – | 3771 |
|
|
2018
Q1 | $328K | Sell |
9,376
-9,329
| -50% | -$326K | ﹤0.01% | 2474 |
|
|
2017
Q4 | $796K | Sell |
18,705
-1,038
| -5% | -$44.2K | ﹤0.01% | 1981 |
|
|
2017
Q3 | $847K | Buy |
19,743
+13,591
| +221% | +$583K | ﹤0.01% | 1783 |
|
|
2017
Q2 | $228K | Buy |
6,152
+3,469
| +129% | +$129K | ﹤0.01% | 2978 |
|
|
2017
Q1 | $146K | Sell |
2,683
-11,988
| -82% | -$652K | ﹤0.01% | 2912 |
|
|
2016
Q4 | $779K | Buy |
+14,671
| New | +$779K | ﹤0.01% | 2517 |
|
|
2016
Q3 | – | Sell |
-2,943
| Closed | -$194K | – | 3077 |
|
|
2016
Q2 | $194K | Sell |
2,943
-16,754
| -85% | -$1.1M | ﹤0.01% | 2762 |
|
|
2016
Q1 | $1.12M | Sell |
19,697
-36,640
| -65% | -$2.08M | ﹤0.01% | 1902 |
|
|
2015
Q4 | $13.3M | Sell |
56,337
-3,087
| -5% | -$726K | 0.01% | 355 |
|
|
2015
Q3 | $9.4M | Buy |
59,424
+27,031
| +83% | +$4.27M | ﹤0.01% | 499 |
|
|
2015
Q2 | $12.3M | Buy |
32,393
+13,034
| +67% | +$4.93M | 0.01% | 476 |
|
|
2015
Q1 | $8.09M | Sell |
19,359
-25,714
| -57% | -$10.7M | ﹤0.01% | 581 |
|
|
2014
Q4 | $12.3M | Sell |
45,073
-14,689
| -25% | -$4.02M | ﹤0.01% | 500 |
|
|
2014
Q3 | $11.6M | Buy |
59,762
+17,795
| +42% | +$3.46M | ﹤0.01% | 526 |
|
|
2014
Q2 | $10.3M | Buy |
41,967
+17,277
| +70% | +$4.23M | ﹤0.01% | 605 |
|
|
2014
Q1 | $6.54M | Buy |
24,690
+6,872
| +39% | +$1.82M | ﹤0.01% | 779 |
|
|
2013
Q4 | $6.47M | Sell |
17,818
-1,672
| -9% | -$607K | ﹤0.01% | 872 |
|
|
2013
Q3 | $10.4M | Buy |
19,490
+5,174
| +36% | +$2.75M | 0.01% | 521 |
|
|
2013
Q2 | $3.35M | Buy |
+14,316
| New | +$3.35M | ﹤0.01% | 1119 |
|